Ballicules › Drugs › Pioglitazone
What it is PPAR-gamma agonist improving insulin sensitivity; type 2 diabetes.
Why this one Durable A1c reduction with no hypoglycemia, and benefit in NAFLD and after stroke in insulin-resistant patients.
What limits it Fluid retention and weight gain, and it precipitates heart failure. Bone fracture risk in women; onset takes weeks.
FDA-approved for
Off-label
FDA label
Read the full label on DailyMed ↗
BOXED WARNING Thiazolidinediones, including pioglitazone, cause or exacerbate congestive heart failure; initiation contraindicated in NYHA Class III/IV heart failure.
FDA dosing Population Start Target Max
Type 2 diabetes mellitus Adult 15 or 30 mg QD (15 mg QD if NYHA Class I/II HF) Titrate by HbA1c 45 mg QD (15 mg QD with strong CYP2C8 inhibitors, e.g., gemfibrozil)
Renal Undefined
Hepatic Obtain liver tests before starting; initiate with caution if abnormal; do not start with active liver disease
Instructions Take once daily without regard to meals Obtain liver tests before initiation; monitor for signs of heart failure after initiation and dose increases
Contraindications Initiation in patients with established NYHA Class III or IV heart failure
Cautions Congestive heart failure/fluid retention (highest risk with insulin) Hypoglycemia with insulin or insulin secretagogues Postmarketing hepatic failure reports Bladder cancer — do not use in active bladder cancer Dose-related edema Increased fracture incidence in females Macular edema
Adverse reactions Upper respiratory tract infection Headache Sinusitis Myalgia Pharyngitis Edema Weight gain Hypoglycemia (combination use)
Pregnancy Limited data; poorly controlled diabetes carries risk; may induce ovulation in anovulatory women.
Lactation No information on presence in human milk.
Cost, est. cash $5–$150/month
Generic entry 2012
Classes and tags
Clinical profile
Therapeutic safety burden 2 / 4
Overdose danger 2 / 4
Weight-gain liability 3 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 0 / 4
Legacy pregnancy category Multiple / indication-, trimester- or formulation-dependent
Defining liability Agent-specific hypoglycemia, ketoacidosis, volume, renal or gastrointestinal toxicity.
Mechanism of action: Pioglitazone ballicule
Open Pioglitazone in the interactive console ↗
Memory aids: mascots and interaction avatars
“Piggy glitter zone Actor”
Open Pioglitazone in the interactive console ↗